Volume 5: Issue 2

The scientific program of the Pulmonary Hypertension Association is guided by the association’s Scientific Leadership Council. The Council includes the following health care professionals:

David B. Badesch, MD, SLC Chair, University of Colorado Health Sciences Center, Denver, Colorado
Robyn J. Barst, MD, SLC Immediate Past Chair, Columbia Presbyterian Medical Center Babies Hospital, New York, New York
Vallerie V. McLaughlin, MD, SLC Vice-Chair, University of Michigan Health System, Ann Arbor, Michigan
Raymond L. Benza, MD, University of Alabama, Birmingham, Alabama
Todd Bull, MD, University of Colorado Health Sciences Center, Denver, Colorado
Richard N. Channick, MD,

Congenital heart defects are among the most common congenital malformations at birth, with an incidence of approximately 8/1000 live births. These defects are characterized by a heterogeneous group of abnormal communications and connections between the cardiac chambers and great vessels with different hemodynamic consequences and hence, varying need for follow-up and interventions. The most common forms are congenital cardiac systemic to pulmonary shunts (ie, ventricular septal defects, atrial septal defects, patent ductus arteriosus) that account for almost 60 % of congenital cardiac malformations.

This discussion was moderated by Erika Berman Rosenzweig, MD, Assistant Professor of Pediatrics (in Medicine), Columbia University College of Physicians and Surgeons, New York, New York. Panel members included Steven H. Abman, MD, Professor of Pediatrics and Director of the Pediatric Heart-Lung Center at The Children’s Hospital, University of Colorado School of Medicine, Denver, Colorado; Dunbar Ivy, MD, Associate Professor of Pediatrics, University of Colorado Health Sciences Center, The Children’s Hospital, Chief of Pediatric Cardiology, and Director of the Pulmonary Hypertension Program, University of Colorado Health Sciences Center, Denver, Colorado; and Sheila G. Haworth, MD, FRCP, Professor of Developmental Cardiology, Institute of Child Health, University College, London, UK, and Lead Clinician at the United Kingdom Pulmonary Hypertension Service for Children.

Hands Across the Ocean: Building a Bridge to an International Pulmonary Hypertension Community

The Scientific Leadership Council of the Pulmonary Hypertension Association

Sheila G. Haworth, MD, Creator of the UK Network for the Care of Children with Pulmonary Hypertension, Reviews Milestones in Clinical Management

Management of Idiopathic PAH in Children: Reexamining the Evolving Treatment Algorithm

Persistent Pulmonary Hypertension of the Newborn: Pathophysiology and Treatment

A Classification System and Treatment Guidelines for PAH Associated with Congenital Heart Disease

• Identifying the Complex Spectrum of Childhood PAH

• Selecting Candidates for Aggressive Treatment

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease